GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lobe Sciences Ltd (OTCPK:LOBEF) » Definitions » Cyclically Adjusted Book per Share

LOBEF (Lobe Sciences) Cyclically Adjusted Book per Share : $0.14 (As of Feb. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Lobe Sciences Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Lobe Sciences's adjusted book value per share for the three months ended in Feb. 2025 was $-0.014. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.14 for the trailing ten years ended in Feb. 2025.

During the past 12 months, Lobe Sciences's average Cyclically Adjusted Book Growth Rate was -20.80% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -15.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Lobe Sciences was -15.10% per year. The lowest was -15.10% per year. And the median was -15.10% per year.

As of today (2025-05-17), Lobe Sciences's current stock price is $0.0215. Lobe Sciences's Cyclically Adjusted Book per Share for the quarter that ended in Feb. 2025 was $0.14. Lobe Sciences's Cyclically Adjusted PB Ratio of today is 0.15.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Lobe Sciences was 1.08. The lowest was 0.05. And the median was 0.11.


Lobe Sciences Cyclically Adjusted Book per Share Historical Data

The historical data trend for Lobe Sciences's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lobe Sciences Cyclically Adjusted Book per Share Chart

Lobe Sciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.31 0.27 0.19 0.17

Lobe Sciences Quarterly Data
May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.19 0.20 0.17 0.13 0.14

Competitive Comparison of Lobe Sciences's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Lobe Sciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lobe Sciences's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lobe Sciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Lobe Sciences's Cyclically Adjusted PB Ratio falls into.


;
;

Lobe Sciences Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Lobe Sciences's adjusted Book Value per Share data for the three months ended in Feb. 2025 was:

Adj_Book= Book Value per Share /CPI of Feb. 2025 (Change)*Current CPI (Feb. 2025)
=-0.014/128.7859*128.7859
=-0.014

Current CPI (Feb. 2025) = 128.7859.

Lobe Sciences Quarterly Data

Book Value per Share CPI Adj_Book
201503 0.267 99.789 0.345
201506 0.257 100.500 0.329
201509 0.226 100.421 0.290
201512 0.087 99.947 0.112
201603 0.080 101.054 0.102
201606 0.073 102.002 0.092
201609 0.057 101.765 0.072
201612 0.031 101.449 0.039
201703 0.070 102.634 0.088
201706 0.053 103.029 0.066
201709 0.047 103.345 0.059
201712 0.026 103.345 0.032
201803 0.012 105.004 0.015
201806 0.003 105.557 0.004
201809 -0.013 105.636 -0.016
201812 -0.125 105.399 -0.153
201903 -0.012 106.979 -0.014
201908 0.413 108.085 0.492
201911 0.383 107.769 0.458
202002 0.378 108.559 0.448
202005 0.355 107.532 0.425
202008 0.383 108.243 0.456
202011 0.346 108.796 0.410
202102 0.324 109.745 0.380
202105 0.609 111.404 0.704
202108 0.239 112.668 0.273
202111 0.000 113.932 0.000
202202 0.082 115.986 0.091
202205 0.046 120.016 0.049
202208 0.009 120.569 0.010
202211 0.001 121.675 0.001
202302 -0.008 122.070 -0.008
202305 0.000 124.045 0.000
202308 -0.002 125.389 -0.002
202311 -0.006 125.468 -0.006
202402 -0.012 125.468 -0.012
202405 -0.005 127.601 -0.005
202408 -0.013 127.838 -0.013
202411 -0.014 127.838 -0.014
202502 -0.014 128.786 -0.014

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Lobe Sciences  (OTCPK:LOBEF) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Lobe Sciences's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.0215/0.14
=0.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Lobe Sciences was 1.08. The lowest was 0.05. And the median was 0.11.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Lobe Sciences Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Lobe Sciences's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Lobe Sciences Business Description

Industry
Traded in Other Exchanges
Address
1771 Robson Street, No. 1614, Vancouver, BC, CAN, V6G 3B7
Lobe Sciences Ltd is a biopharmaceutical company committed to discovering and developing patient-focused medicines for orphan and rare diseases. It is engaged in drug research and development to improve brain and mental health and wellness. The company plans to commercialize a medical food named Altemia for the treatment of Sickle Cell Disease and has other drugs in pipeline such as L-130 Treatment for Chronic Cluster Headache, L-131 Treatment for Pediatric Anxiety and S-100 Treatment for Sickle Cell Disease.